Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2009 | 1 |
2010 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibody.
Eur J Immunol. 2011 Jul;41(7):1832-42. doi: 10.1002/eji.201041258. Epub 2011 Jun 6.
Eur J Immunol. 2011.
PMID: 21538351
Free PMC article.
Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes.
Bresson D, Fradkin M, Manenkova Y, Rottembourg D, von Herrath M.
Bresson D, et al.
Mol Ther. 2010 Feb;18(2):307-16. doi: 10.1038/mt.2009.197. Epub 2009 Aug 18.
Mol Ther. 2010.
PMID: 19690518
Free PMC article.
Item in Clipboard
Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.
Bresson D, Togher L, Rodrigo E, Chen Y, Bluestone JA, Herold KC, von Herrath M.
Bresson D, et al.
J Clin Invest. 2006 May;116(5):1371-81. doi: 10.1172/JCI27191. Epub 2006 Apr 20.
J Clin Invest. 2006.
PMID: 16628253
Free PMC article.
Item in Clipboard
Cite
Cite